Cargando…
Update on clinical research and state of the art management of patients with advanced sarcomas and GIST
Sarcomas constitute a rare group of malignancies. According to histology, different treatment options are effective. For gastrointestinal stromal tumours (GISTs), targeted treatment with imatinib controls about 20% of advanced or metastatic disease, whereas chemotherapy is more effective for the res...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070248/ https://www.ncbi.nlm.nih.gov/pubmed/27843616 http://dx.doi.org/10.1136/esmoopen-2016-000065 |